SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-051390
Filing Date
2024-04-24
Accepted
2024-04-24 20:59:26
Documents
2
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2412678-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2412678-1_3seq1.xml 3 15333
2 EXHIBIT 24.1 tm2412678d1_ex24-1.htm EX-24.1 8207
  Complete submission text file 0001104659-24-051390.txt   25307
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Issuer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 ALLEN ROAD 2ND FLOOR BASKING RIDGE NJ 07920
Business Address
Nisco James (Reporting) CIK: 0002020260 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33650 | Film No.: 24872498